D. E. Shaw & Co., Inc. Bridge Bio Pharma, Inc. Transaction History

D. E. Shaw & Co., Inc.

$156 Billion
Q3 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 2,252,762 shares of BBIO stock, worth $150 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,252,762

Previous 2,081,253 8.24%

Holding current value

$150 Million

Previous $89.9 Million 30.2%

% of portfolio

0.07%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$42.78 - $54.29 $7.34 Million - $9.31 Million	171,509 Added 8.24%	2,252,762 $117 Million
Q2 2025 Aug 14, 2025	BUY	$30.14 - $45.12 $60.2 Million - $90.2 Million	1,998,104 Added 2403.04%	2,081,253 $89.9 Million
Q1 2025 May 15, 2025	BUY	$28.12 - $37.59 $2.34 Million - $3.13 Million	83,149 New	83,149 $2.87 Million
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $3.43 Million - $4.49 Million	-143,382 Reduced 63.97%	80,746 $2.06 Million
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $4.46 Million - $6.01 Million	-193,760 Reduced 46.37%	224,128 $5.68 Million

Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $13.9 Million - $20.5 Million	-506,977 Reduced 54.82%	417,888 $12.9 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $10 Million - $18.3 Million	-416,378 Reduced 31.04%	924,865 $37.3 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $4.93 Million - $10.2 Million	-291,743 Reduced 17.87%	1,341,243 $35.4 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $7.96 Million - $10.8 Million	-599,035 Reduced 26.84%	1,632,986 $28.1 Million
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $3.36 Million - $8.7 Million	-468,803 Reduced 17.36%	2,232,021 $37 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $2.31 Million - $3.95 Million	342,755 Added 14.54%	2,700,824 $20.6 Million
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $717,696 - $1.12 Million	-90,390 Reduced 3.69%	2,358,069 $23.4 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $247,834 - $577,487	-47,569 Reduced 1.91%	2,448,459 $22.2 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $8.88 Million - $20.8 Million	1,209,939 Added 94.08%	2,496,028 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $12.7 Million - $59.8 Million	1,119,497 Added 672.0%	1,286,089 $21.5 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $100,395 - $137,602	-2,142 Reduced 1.27%	166,592 $7.81 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $6.64 Million - $9.14 Million	142,975 Added 555.05%	168,734 $10.3 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $1.43 Million - $1.86 Million	25,759 New	25,759 $1.59 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $2.5 Million - $4.02 Million	-112,589 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $1.81 Million - $4.08 Million	112,589 New	112,589 $3.27 Million

Others Institutions Holding BBIO

# of Institutions

446

Shares Held

184M

Call Options Held

11.3M

Put Options Held

1.84M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account